{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:51:52Z","timestamp":1784069512113,"version":"3.55.0"},"publisher-location":"Chichester, UK","reference-count":43,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002810","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:38:44Z","timestamp":1069367924000},"source":"Crossref","is-referenced-by-count":17,"title":["Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles"],"prefix":"10.1002","author":[{"given":"S","family":"Daya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gunby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2000,7,24]]},"reference":[{"key":"10.1002\/14651858.CD002810-BIB1|cit1","series-title":"Fertility Society of Australia\/ Australian Gynecological Endoscopy Society Annual Meeting Abstract Book","first-page":"FSA 46","article-title":"Recombinant human follicle stimulating hormone (Gonal-F, Serono) compared to urinary follicle stimulating hormone (Metrodin) in IVF cycles: a randomised control study [abstract]","author":"Alvino","year":"1995"},{"issue":"1","key":"10.1002\/14651858.CD002810-BIB2|cit2","first-page":"O","article-title":"An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum \u00df 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF\/ICSI treatment","volume":"14","author":"Berger","year":"1999","journal-title":"Human Reproduction (Abstract )"},{"key":"10.1002\/14651858.CD002810-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","article-title":"Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques","volume":"12","author":"Bergh","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB4|cit4","series-title":"11th World Congress of In Vitro Fertilization and Human Reproductive Genetics (Abstract)","first-page":"P196","article-title":"Recombinant FSH versus urinary FSH in non-down regulated poorly responding patients","author":"Ferraretti","year":"1999"},{"key":"10.1002\/14651858.CD002810-BIB5|cit5","first-page":"P","article-title":"Does recombinant FSH increase embryo viability in poor responder patients?","volume":"14","author":"Ferraretti","year":"1999","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB7|cit6","first-page":"P","article-title":"A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH","volume":"14","author":"Baruffi","year":"1999","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB6|cit7","series-title":"11th World Congress of In Vitro Fertilization and Human Reproductive Genetics (Abstract)","first-page":"O","article-title":"A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH","author":"Franco","year":"1999"},{"key":"10.1002\/14651858.CD002810-BIB8|cit8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/09513590009167653","article-title":"A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH","volume":"14","author":"Franco","year":"2000","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD002810-BIB9|cit9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","article-title":"A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection","volume":"15","author":"Frydman","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB10|cit10","series-title":"11th World Congress of In Vitro Fertilization and Human Reproductive Genetics (Abstract)","first-page":"P","article-title":"Recombinant FSH versus highly purified urinary FSH - our experience","author":"Ghosh","year":"1999"},{"key":"10.1002\/14651858.CD002810-BIB11|cit11","first-page":"O","article-title":"A randomized prospective study of the effect of LH on follicular growth and development","volume":"12","author":"Gordon","year":"1997","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB12|cit12","doi-asserted-by":"crossref","first-page":"O","DOI":"10.1093\/humrep\/12.Suppl_2.53-b","article-title":"Effect of differing doses of LH on oocyte maturation and fertilization","volume":"12","author":"Gordon","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1093\/oxfordjournals.humrep.a135866","article-title":"Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial","volume":"10","author":"Hedon","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB14|cit14","first-page":"P","article-title":"A prospective trial comparing Puregon 150 IU and Metrodin-HP 225 IU as a fixed-dose regimen in IVF treatment","volume":"13","author":"Andersen","year":"1998","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/14.10.2442","article-title":"A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP) in a fixed-dose regimen in women undergoing ovarian stimulation","volume":"14","author":"Hoomans","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB16|cit16","series-title":"11th World Congress on In Vitro Fertilization and Human Reproductive Genetics","first-page":"379","article-title":"Comparison of four different gonadotropins for ovarian stimulation in IVF treatment","author":"Kornilov","year":"1999"},{"key":"10.1002\/14651858.CD002810-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/humrep\/15.5.1021","article-title":"Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin-HP)","volume":"15","author":"Lenton","year":"2000","journal-title":"Human Reproduction"},{"issue":"13","key":"10.1002\/14651858.CD002810-BIB18|cit18","first-page":"FC","article-title":"Highly purified gonadotropin and recombinant gonadotropin: study in IVF cycles","volume":"13 Suppl","author":"Machado","year":"1999","journal-title":"Gynaecological Endocrinology (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB19|cit19","first-page":"R","article-title":"Initial results from the comparison of recombinant FSH and urinary FSH in an IVF programme","volume":"12","author":"Manassiev","year":"1997","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB20|cit20","series-title":"American Fertility Society Annual Meeting (Abstract)","first-page":"O","article-title":"A randomized, comparative multicenter clinical trial of recombinant and urinary human FSH in in vitro fertilization and embryo transfer (IVFET)","author":"O'Dea","year":"1993"},{"key":"10.1002\/14651858.CD002810-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","article-title":"A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization","volume":"10","author":"Out","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB22|cit22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0015-0282(16)57300-2","article-title":"Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization","volume":"63","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD002810-BIB23|cit23","series-title":"The First Congress on Controversies in Obstetrics, Gynecology & Infertility, Prague, Czech Republic","first-page":"8","article-title":"A randomised, prospective, assessor-blind, multicentre study to compare the efficacy and safety of Gonal-F with that of Metrodin HP for induction of superovulation in women undergoing ART","author":"Sutter","year":"1999"},{"key":"10.1002\/14651858.CD002810-BIB24|cit24","first-page":"45-6 (Abs # O-1","article-title":"Controlled ovarian stimulation during assisted reproduction techniques: a randomized, prospective, assessor-blind multicentre study comparing the efficacy and safety of recombinant FSH (Gonal-F) with highly purified urinary FSH (Metrodin HP) [abstract]","volume":"Abstract Book 1","author":"Schats","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1002\/14651858.CD002810-BIB25|cit25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02214125","article-title":"Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study","volume":"12","author":"Fisch","year":"1995","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD002810-BIB26|cit26","first-page":"206","article-title":"A prospective randomized comparative cohort study of either recombinant FSH (Puregon ) or urinary FSH (Metrodin) in in vitro fertilization treatment","volume":"4","author":"Kahn","year":"1999","journal-title":"Middle East Fertility Society Journal"},{"issue":"1","key":"10.1002\/14651858.CD002810-BIB27|cit27","first-page":"P","article-title":"Recombinant follicle-stimulating hormone (Puregon) versus urinary FSH in in vitro fertilization","volume":"70 Suppl","author":"Mantzavinos","year":"1998","journal-title":"Fertility & Sterility (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB28|cit28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/oxfordjournals.humrep.a019332","article-title":"Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon)","volume":"11","author":"Mitchell","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB29|cit29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0015-0282(97)81490-2","article-title":"Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins","volume":"68","author":"Out","year":"1997","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD002810-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/14.6.1431","article-title":"Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome","volume":"14","author":"Raga","year":"1999","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD002810-BIB31|cit31","first-page":"144","article-title":"In IVF, administration of recombinant FSH (Puregon) gives a significantly higher mean number of oocytes, fertilized oocytes and good embryos compared with administration of purified urinary FSH (Metrodin)","volume":"9 Suppl","author":"Sunde","year":"1994","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB32|cit32","series-title":"11th World Congress on In Vitro Fertilization and Human Reproductive Genetics","first-page":"211","article-title":"Analysis of clinically important parameters in follicular augmentation with a fixed dose regime of recFSH vs uFSH-HP and HMG after GnRH - \"long protocol\" - down-regulation","author":"Zech","year":"1999"},{"key":"10.1002\/14651858.CD002810-BIB33|cit33","first-page":"R","article-title":"Comparison of ovulation induction with rFSH and highly purified urinary FSH (FSH HP) in IVF","volume":"14","author":"Gomez-Parga","year":"1999","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB34|cit34","first-page":"R","article-title":"An open, randomized, group-comparative study to investigate the efficacy oUregon versus Metrodin in a fixed dose protocol in [in]fertile subjects undergoing in-vitro fertilization","volume":"14","author":"Soong","year":"1999","journal-title":"Human Reproduction (Abstract)"},{"key":"10.1002\/14651858.CD002810-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1210\/endo-129-5-2623","article-title":"Comparative in vitro and in vivo studies on the biological properties of recombinant human follicle stimulating hormone","volume":"129","author":"Mannaerts","year":"1991","journal-title":"Endocrinology"},{"key":"10.1002\/14651858.CD002810-BIB36|cit36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/sim.4780060306","article-title":"Why do we need systematic overviews of randomized trials?","volume":"6","author":"Peto","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD002810-BIB37|cit37","first-page":"53","article-title":"Gonadotrophin isoform pattern in different pharmaceutical preparations","volume-title":"Gonadotropin Isoforms: Facts and Future. Serono Fertility Series","volume":"2","author":"Robertson","year":"1997"},{"key":"10.1002\/14651858.CD002810-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/oxfordjournals.humrep.a136220","article-title":"Variability in the immunoreactive and bioactive follicle stimulating hormone content of human urinary menopausal gonadotrophin preparations","volume":"10","author":"Rodgers","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1210\/en.130.5.2820","article-title":"Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms","volume":"139","author":"Stanton","year":"1992","journal-title":"Endocrinology"},{"key":"10.1002\/14651858.CD002810-BIB40|cit40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/oxfordjournals.humrep.a136734","article-title":"Immunological and biological potencies of different molecular species of gonadotropins","volume":"3","author":"Ulloa-Aguirre","year":"1988","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB41|cit41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.humrep.a137550","article-title":"Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone","volume":"7","author":"Ulloa-Aguirre","year":"1992","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002810-BIB42|cit42","first-page":"43","article-title":"Isoforms of human gonadotrophins under different physiological conditions","volume-title":"Gonadotropin Isoforms: Facts and Future. Serono Fertility Series","volume":"2","author":"Wide","year":"1997"},{"key":"10.1002\/14651858.CD002810-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/humrep\/14.9.2207","article-title":"Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction","volume":"14","author":"Daya","year":"1999","journal-title":"Human Reproduction"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002810.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T10:05:11Z","timestamp":1682589911000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002810"}},"subtitle":[],"editor":[{"given":"Salim","family":"Daya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2000,7,24]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002810","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD002810.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2000,7,24]]}}}